Crinetics Pharmaceuticals Inc (CRNX)
51.38
-0.53
(-1.02%)
USD |
NASDAQ |
May 17, 16:00
51.38
0.00 (0.00%)
After-Hours: 20:00
Crinetics Pharmaceuticals Profit Margin (Quarterly): -10.46K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -10.46K% |
| December 31, 2023 | |
| September 30, 2023 | -16.61K% |
| June 30, 2023 | -5.16K% |
| March 31, 2023 | -1.72K% |
| Date | Value |
|---|---|
| December 31, 2022 | -6.35K% |
| September 30, 2022 | -9.15K% |
| June 30, 2022 | -9.65K% |
| March 31, 2022 | -1.11K% |
| December 31, 2021 | -2.86K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-16.61K%
Minimum
Sep 2023
-1.11K%
Maximum
Mar 2022
-7.01K%
Average
-6.35K%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 23.63% |
| Geron Corp | -18.22K% |
| Madrigal Pharmaceuticals Inc | -- |
| PTC Therapeutics Inc | -43.58% |
| Syndax Pharmaceuticals Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -47.16% |
| Return on Assets | -41.13% |
| Return on Invested Capital | -47.16% |
| Operating Margin (Quarterly) | -11.49K% |
| Return on Net Operating Assets | -465.2% |